HIGHBRIDGE CAPITAL MANAGEMENT
HCM is a global alternative investment management firm launched in 1992. Since its inception, the company has developed a diversified investment platform that includes hedge funds, traditional investment management products and debt and private equity investments with longer-term holding periods. With over 300 employees, including almost 100 investment professionals, HCM manages approximately $21 billion of capital for some of the world's most prominent institutional investors, public and corporate pension funds, endowments, foundations and family offices.
HIGHBRIDGE CAPITAL MANAGEMENT
Industry:
Finance Financial Services Venture Capital
Founded:
1992-01-01
Status:
Active
Contact:
212 287 4000
Email Addresses:
[email protected]
Technology used in webpage:
SPF SSL By Default Google Font API Domain Not Resolving Google Maps Microsoft Azure DNS Cloudflare JS CDN JS Cloudflare DNS Akamai Hosted
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-12-28 | CompoSecure | Highbridge Capital Management investment in Post-IPO Equity - CompoSecure | 175 M USD |
| 2021-12-22 | Urgently | Highbridge Capital Management investment in Debt Financing - Urgently | 75 M USD |
| 2021-12-08 | BigBear.ai | Highbridge Capital Management investment in Post-IPO Debt - BigBear.ai | 200 M USD |
| 2021-11-04 | Lime | Highbridge Capital Management investment in Convertible Note - Lime | 418 M USD |
| 2021-09-20 | Santhera Pharmaceuticals | Highbridge Capital Management investment in Post-IPO Debt - Santhera Pharmaceuticals | 25 M CHF |
| 2021-09-20 | Santhera Pharmaceuticals | Highbridge Capital Management investment in Post-IPO Equity - Santhera Pharmaceuticals | 20 M CHF |
| 2021-05-24 | Quotient Biodiagnostics | Highbridge Capital Management investment in Post-IPO Debt - Quotient Biodiagnostics | 95 M USD |
| 2021-02-16 | Gamida Cell | Highbridge Capital Management investment in Post-IPO Debt - Gamida Cell | 75 M USD |
| 2020-06-04 | Santhera Pharmaceuticals | Highbridge Capital Management investment in Post-IPO Debt - Santhera Pharmaceuticals | 20 M CHF |
| 2020-03-12 | Protalix BioTherapeutics | Highbridge Capital Management investment in Post-IPO Equity - Protalix BioTherapeutics | 43.7 M USD |
More informations about "Highbridge Capital Management"
Highbridge Capital Management LLC
Founded in 1992, Highbridge Capital Management is a global alternative investment firm …See details»
Highbridge Capital Management - Wikipedia
Highbridge Capital Management, LLC is a multi-strategy alternative investment management firm founded by Glenn Dubin and Henry Swieca in 1992. In 2004, it was purchased by JPMorgan Chase; as of 2019, it had about $3.9 billion in assets under management, out of $150 billion in JPMorgan's global alternatives division. See details»
Highbridge Capital Management - LinkedIn
Highbridge Capital Management | 7,700 followers on LinkedIn. Highbridge Capital Management is a global alternative investment firm offering relative value, credit and volatility focused solutions ...See details»
Highbridge Capital Management: Building a Sustainable …
In 2010 Glenn Dubin reflected upon the enduring organization and culture he and co-founder …See details»
Highbridge Capital Management - Company Database - Wall …
Highbridge Capital Management is an alternative investment management organization …See details»
Highbridge Capital Management - Crunchbase
Highbridge Capital Management may be growing as it has taken ownership of Gamida Cell, a move that typically involves a significant financial investment and indicates an expansion of the company's portfolio. The acquisition of Gamida …See details»
Highbridge Capital Management - Hedge Fund
Highbridge Capital Management is an alternative investment firm offering credit and volatility …See details»
Highbridge Capital Management, LLC - InterFishMarket®
Highbridge Capital Management is an alternative investment management organization …See details»
Glenn Dubin - Dubin Family Foundation
Glenn co-founded Highbridge Capital Management LLC, a multi-strategy hedge fund that he grew into a diversified alternative asset management company with over $35 billion of capital under management. In 2009, Highbridge was …See details»
Highbridge Capital Management appoints CEO
Jul 15, 2013 Highbridge Capital Management, LLC, a global alternative investment …See details»
Highbridge Capital Management - PitchBook
Highbridge Capital Management has invested in or acquired companies like BioLineRx, …See details»
Highbridge Capital Management - Leadership Team - The Org
The Leadership Team at Highbridge Capital Management is responsible for setting strategic …See details»
Highbridge Capital Management: Building a Sustainable …
In 2010 Glenn Dubin reflected upon the enduring organization and culture he and co-founder …See details»
Highbridge Capital Management: Building a Sustainable …
In 2010, Glenn Dubin is reflected in a strong organization and culture, he and co-founder Henry …See details»
Highbridge Capital Management Names Todd Builione President
Apr 8, 2011 Finsbury Group Tripp Kyle / David Millar, +1 212-303-7600 …See details»
Highbridge Capital Management - Massinvestor Venture Capital …
Highbridge Capital Management is an alternative investment management organization …See details»
Highbridge Capital Management
Highbridge Capital Management, LLC is a hedge fund and alternative investment management …See details»
Highbridge Capital Management - Private Equity International
Founded in 1992, Highbridge Capital Management is a New York-headquartered firm with an …See details»
Free Highbridge Capital Management: Building a Sustainable …
Harvard Case - Highbridge Capital Management: Building a Sustainable Organization …See details»
H.I.G. Capital Completes Acquisition of Converge Technology …
Apr 22, 2025 H.I.G.’s equity funds invest in management buyouts, recapitalizations, and …See details»